中金:潤地(1109.HK)配股攤薄效應有限 板塊調整為買入機會
中金公司表示,華潤置地(1109.HK)配股帶來的攤薄效應有限,因新股僅佔公司發行後總股本的2.8%,引發的板塊股價調整提供了買入機會,考慮到地產行業的低估值等因素,短期內更多公司配股的可能性較低。中金續指,潤地財務管理審慎、資產負債情況健康,今年以來公司購地積極,新股發行將有助於其滿足短期財務需求。
中金又指,一般來説股價上漲、高估值、資產負債情況緊張的公司更傾向於發行新股融資,如果優質地產商實施配股,建議投資者參與,相信其穩健和持續的成長將帶來不錯的回報。近期部分城市已出現積極的房產政策調整,如果基本面惡化超預期,政策調整的空間可能更大,該行認為主要地產商銷售額有望穩健增長、盈利增長的可見性強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.